市場調査レポート

商品コード

1128165

世界の核医学治療市場：考察と予測 (2028年まで)

Global Therapeutic Nuclear Medicines Market Insights and Forecast to 2028

出版日: 2022年09月26日 | 発行: QYResearch

| ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 763,665円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,145,497円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,527,330円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.85円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、核医学治療 (Therapeutic Nuclear Medicines) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

核医学治療の製品概要
市場：タイプ別
- 世界の核医学治療の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Radium-223
- Lutetium-177
- Iodine-131
- Other
市場：アプリケーション別
- 世界の核医学治療の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
調査目的
対象期間

第2章レポート概要

世界の核医学治療の販売推定および予測 2017-2028
世界の核医学治療の収益推定および予測 2017-2028
世界の核医学治療の収益：地域別: 2017 VS 2021 VS 2028
世界の核医学治療の販売：地域別
- 世界の核医学治療の販売：地域別 (2017-2022)
- 世界の販売核医学治療：地域別 (2023-2028)
世界の核医学治療の収益：地域別
- 世界の核医学治療の収益：地域別 (2017-2022)
- 世界の核医学治療の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界の核医学治療の販売：メーカー別
- 世界の核医学治療の上位メーカー：販売別 (2017-2022)
- 世界の核医学治療の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：核医学治療2021
世界の核医学治療の収益：メーカー別
- 世界の核医学治療の収益：メーカー別 (2017-2022)
- 世界の核医学治療の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：核医学治療の収益 2021
世界の核医学治療の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界の核医学治療の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界の核医学治療のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界の核医学治療の販売：タイプ別
- 世界の核医学治療の販売実績：タイプ別 (2017-2022)
- 世界の核医学治療の販売予測：タイプ別 (2023-2028)
- 世界の核医学治療の販売市場シェア：タイプ別 (2017-2028)
世界の核医学治療の収益：タイプ別
- 世界の核医学治療の収益実績：タイプ別 (2017-2022)
- 世界の核医学治療の収益予測：タイプ別 (2023-2028)
- 世界の核医学治療の収益市場シェア：タイプ別 (2017-2028)
世界の核医学治療の価格：タイプ別
- 世界の核医学治療の価格：タイプ別 (2017-2022)
- 世界の核医学治療の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界の核医学治療の販売：アプリケーション別
- 世界の核医学治療の販売実績：アプリケーション別 (2017-2022)
- 世界の核医学治療の販売予測：アプリケーション別 (2023-2028)
- 世界の核医学治療の販売市場シェア：アプリケーション別 (2017-2028)
世界の核医学治療の収益：アプリケーション別
- 世界の核医学治療の収益実績：アプリケーション別 (2017-2022)
- 世界の核医学治療の収益予測：アプリケーション別 (2023-2028)
- 世界の核医学治療の収益市場シェア：アプリケーション別 (2017-2028)
世界の核医学治療の価格：アプリケーション別
- 世界の核医学治療の価格：アプリケーション別 (2017-2022)
- 世界の核医学治療の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米の核医学治療市場規模：タイプ別
- 北米の核医学治療の販売：タイプ別 (2017-2028)
- 北米の核医学治療の収益：タイプ別 (2017-2028)
北米の核医学治療市場規模：アプリケーション別
- 北米の核医学治療の販売：アプリケーション別 (2017-2028)
- 北米の核医学治療の収益：アプリケーション別 (2017-2028)
北米の核医学治療市場規模：国別
- 北米の核医学治療の販売：国別 (2017-2028)
- 北米の核医学治療の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州の核医学治療市場規模：タイプ別
- 欧州の核医学治療の販売：タイプ別 (2017-2028)
- 欧州の核医学治療の収益：タイプ別 (2017-2028)
欧州の核医学治療市場規模：アプリケーション別
- 欧州の核医学治療の販売：アプリケーション別 (2017-2028)
- 欧州の核医学治療の収益：アプリケーション別 (2017-2028)
欧州の核医学治療市場規模：国別
- 欧州の核医学治療の販売：国別 (2017-2028)
- 欧州の核医学治療の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋の核医学治療市場規模：タイプ別
- アジア太平洋の核医学治療の販売：タイプ別 (2017-2028)
- アジア太平洋の核医学治療の収益：タイプ別 (2017-2028)
アジア太平洋の核医学治療市場規模：アプリケーション別
- アジア太平洋の核医学治療の販売：アプリケーション別 (2017-2028)
- アジア太平洋の核医学治療の収益：アプリケーション別 (2017-2028)
アジア太平洋の核医学治療市場規模：地域別
- アジア太平洋の核医学治療の販売：地域別 (2017-2028)
- アジア太平洋の核医学治療の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア
- フィリピン

第9章ラテンアメリカ

ラテンアメリカの核医学治療市場規模：タイプ別
- ラテンアメリカの核医学治療の販売：タイプ別 (2017-2028)
- ラテンアメリカの核医学治療の収益：タイプ別 (2017-2028)
ラテンアメリカの核医学治療市場規模：アプリケーション別
- ラテンアメリカの核医学治療の販売：アプリケーション別 (2017-2028)
- ラテンアメリカの核医学治療の収益：アプリケーション別 (2017-2028)
ラテンアメリカの核医学治療市場規模：国別
- ラテンアメリカの核医学治療の販売：国別 (2017-2028)
- ラテンアメリカの核医学治療の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン

第10章中東・アフリカ

中東・アフリカの核医学治療市場規模：タイプ別
- 中東・アフリカの核医学治療の販売：タイプ別 (2017-2028)
- 中東・アフリカの核医学治療の収益：タイプ別 (2017-2028)
中東・アフリカの核医学治療市場規模：アプリケーション別
- 中東・アフリカの核医学治療の販売：アプリケーション別 (2017-2028)
- 中東・アフリカの核医学治療の収益：アプリケーション別 (2017-2028)
中東・アフリカの核医学治療市場規模：国別
- 中東・アフリカの核医学治療の販売：国別 (2017-2028)
- 中東・アフリカの核医学治療の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes

第12章業界チェーンと販売チャネルの分析

核医学治療業界チェーン分析
核医学治療主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
核医学治療生産形態とプロセス
核医学治療販売およびマーケティング
- 核医学治療販売チャネル
- 核医学治療卸業者
核医学治療顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

核医学治療業界動向
核医学治療市場の促進要因
核医学治療市場の課題
核医学治療市場の抑制要因

第14章世界の核医学治療の主な市場調査結果

第15章付録

図表

Table 1. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Radium-223
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Iodine-131
Table 5. Major Manufacturers of Other
Table 6. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
Table 9. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)
Table 10. Global Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
Table 11. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2023-2028)
Table 12. Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2022)
Table 14. Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2023-2028)
Table 16. Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2017-2022)
Table 18. Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2017-2022)
Table 20. Therapeutic Nuclear Medicines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2021)
Table 23. Therapeutic Nuclear Medicines Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Therapeutic Nuclear Medicines Product Offered
Table 25. Date of Manufacturers Enter into Therapeutic Nuclear Medicines Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 28. Global Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 29. Global Therapeutic Nuclear Medicines Sales Share by Type (2017-2022)
Table 30. Global Therapeutic Nuclear Medicines Sales Share by Type (2023-2028)
Table 31. Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Therapeutic Nuclear Medicines Revenue Share by Type (2017-2022)
Table 34. Global Therapeutic Nuclear Medicines Revenue Share by Type (2023-2028)
Table 35. Therapeutic Nuclear Medicines Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 38. Global Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 39. Global Therapeutic Nuclear Medicines Sales Share by Application (2017-2022)
Table 40. Global Therapeutic Nuclear Medicines Sales Share by Application (2023-2028)
Table 41. Global Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Therapeutic Nuclear Medicines Revenue Share by Application (2017-2022)
Table 44. Global Therapeutic Nuclear Medicines Revenue Share by Application (2023-2028)
Table 45. Therapeutic Nuclear Medicines Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 48. North America Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 49. North America Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 52. North America Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 53. North America Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 56. North America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 57. North America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 60. Europe Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 61. Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 64. Europe Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 65. Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 68. Europe Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 69. Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
Table 107. Novartis AG Corporation Information
Table 108. Novartis AG Description and Major Businesses
Table 109. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis AG Recent Developments
Table 112. Bayer Corporation Information
Table 113. Bayer Description and Major Businesses
Table 114. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Recent Developments
Table 117. China Isotope & Radiation Corporation Information
Table 118. China Isotope & Radiation Description and Major Businesses
Table 119. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. China Isotope & Radiation Recent Developments
Table 122. Q BioMed Corporation Information
Table 123. Q BioMed Description and Major Businesses
Table 124. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Q BioMed Recent Developments
Table 127. Curium Pharmaceuticals Corporation Information
Table 128. Curium Pharmaceuticals Description and Major Businesses
Table 129. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Curium Pharmaceuticals Recent Developments
Table 132. Jubilant DraxImage Corporation Information
Table 133. Jubilant DraxImage Description and Major Businesses
Table 134. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Jubilant DraxImage Recent Developments
Table 137. Dongcheng Corporation Information
Table 138. Dongcheng Description and Major Businesses
Table 139. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Dongcheng Recent Developments
Table 142. Lantheus Corporation Information
Table 143. Lantheus Description and Major Businesses
Table 144. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Lantheus Recent Developments
Table 147. Acrotech Biopharma. Corporation Information
Table 148. Acrotech Biopharma. Description and Major Businesses
Table 149. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Acrotech Biopharma. Recent Developments
Table 152. Progenics Pharmaceuticals Corporation Information
Table 153. Progenics Pharmaceuticals Description and Major Businesses
Table 154. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Progenics Pharmaceuticals Recent Developments
Table 157. International Isotopes Corporation Information
Table 158. International Isotopes Description and Major Businesses
Table 159. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. International Isotopes Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Therapeutic Nuclear Medicines Distributors List
Table 165. Therapeutic Nuclear Medicines Customers List
Table 166. Therapeutic Nuclear Medicines Market Trends
Table 167. Therapeutic Nuclear Medicines Market Drivers
Table 168. Therapeutic Nuclear Medicines Market Challenges
Table 169. Therapeutic Nuclear Medicines Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. Therapeutic Nuclear Medicines Product Picture
Figure 3. Global Therapeutic Nuclear Medicines Market Share by Type in 2021 & 2028
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Nuclear Medicines Market Share by Application in 2021 & 2028
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Therapeutic Nuclear Medicines Report Years Considered
Figure 13. Global Therapeutic Nuclear Medicines Sales 2017-2028 (K Units)
Figure 14. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Therapeutic Nuclear Medicines Revenue 2017-2028 (US$ Million)
Figure 16. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)
Figure 18. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2023-2028)
Figure 19. North America Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
Figure 20. North America Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Therapeutic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Therapeutic Nuclear Medicines in the World: Market Share by Therapeutic Nuclear Medicines Revenue in 2021
Figure 31. Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 33. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 34. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 35. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 36. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 37. North America Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 38. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 39. North America Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 40. North America Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
Figure 41. North America Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
Figure 42. U.S. Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 45. Europe Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 46. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 47. Europe Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 48. Europe Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
Figure 49. Europe Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
Figure 50. Germany Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 51. France Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Therapeutic Nuclear Medicines Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Therapeutic Nuclear Medicines Revenue Share by Region (2017-2028)
Figure 61. China Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 64. India Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 72. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 74. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
Figure 76. Latin America Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
Figure 77. Mexico Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
Figure 86. Turkey Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
Figure 89. Therapeutic Nuclear Medicines Value Chain
Figure 90. Therapeutic Nuclear Medicines Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

This research report focuses on the Therapeutic Nuclear Medicines Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Therapeutic Nuclear Medicines Product Introduction
1.2 Market by Type
- 1.2.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Radium-223
- 1.2.3 Lutetium-177
- 1.2.4 Iodine-131
- 1.2.5 Other
1.3 Market by Application
- 1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Thyroid
- 1.3.3 Bone Metastasis
- 1.3.4 Lymphoma
- 1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic Nuclear Medicines Sales by Region
- 2.4.1 Global Therapeutic Nuclear Medicines Sales by Region (2017-2022)
- 2.4.2 Global Sales Therapeutic Nuclear Medicines by Region (2023-2028)
2.5 Global Therapeutic Nuclear Medicines Revenue by Region
- 2.5.1 Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022)
- 2.5.2 Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers
- 3.1.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Sales (2017-2022)
- 3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Nuclear Medicines in 2021
3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturers
- 3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2021
3.3 Global Therapeutic Nuclear Medicines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Therapeutic Nuclear Medicines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Therapeutic Nuclear Medicines Sales by Type
- 4.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Type (2017-2022)
- 4.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic Nuclear Medicines Revenue by Type
- 4.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Type (2017-2022)
- 4.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic Nuclear Medicines Price by Type
- 4.3.1 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
- 4.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Therapeutic Nuclear Medicines Sales by Application
- 5.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Application (2017-2022)
- 5.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic Nuclear Medicines Revenue by Application
- 5.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Application (2017-2022)
- 5.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic Nuclear Medicines Price by Application
- 5.3.1 Global Therapeutic Nuclear Medicines Price by Application (2017-2022)
- 5.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028)

6 North America

6.1 North America Therapeutic Nuclear Medicines Market Size by Type
- 6.1.1 North America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
- 6.1.2 North America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
6.2 North America Therapeutic Nuclear Medicines Market Size by Application
- 6.2.1 North America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
- 6.2.2 North America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
6.3 North America Therapeutic Nuclear Medicines Market Size by Country
- 6.3.1 North America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
- 6.3.2 North America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada

7 Europe

7.1 Europe Therapeutic Nuclear Medicines Market Size by Type
- 7.1.1 Europe Therapeutic Nuclear Medicines Sales by Type (2017-2028)
- 7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
7.2 Europe Therapeutic Nuclear Medicines Market Size by Application
- 7.2.1 Europe Therapeutic Nuclear Medicines Sales by Application (2017-2028)
- 7.2.2 Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
7.3 Europe Therapeutic Nuclear Medicines Market Size by Country
- 7.3.1 Europe Therapeutic Nuclear Medicines Sales by Country (2017-2028)
- 7.3.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Type
- 8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic Nuclear Medicines Market Size by Application
- 8.2.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic Nuclear Medicines Market Size by Region
- 8.3.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines

9 Latin America

9.1 Latin America Therapeutic Nuclear Medicines Market Size by Type
- 9.1.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
- 9.1.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
9.2 Latin America Therapeutic Nuclear Medicines Market Size by Application
- 9.2.1 Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
- 9.2.2 Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
9.3 Latin America Therapeutic Nuclear Medicines Market Size by Country
- 9.3.1 Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
- 9.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Type
- 10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Application
- 10.2.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country
- 10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 Novartis AG
- 11.1.1 Novartis AG Corporation Information
- 11.1.2 Novartis AG Overview
- 11.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Novartis AG Recent Developments
11.2 Bayer
- 11.2.1 Bayer Corporation Information
- 11.2.2 Bayer Overview
- 11.2.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Bayer Recent Developments
11.3 China Isotope & Radiation
- 11.3.1 China Isotope & Radiation Corporation Information
- 11.3.2 China Isotope & Radiation Overview
- 11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 China Isotope & Radiation Recent Developments
11.4 Q BioMed
- 11.4.1 Q BioMed Corporation Information
- 11.4.2 Q BioMed Overview
- 11.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Q BioMed Recent Developments
11.5 Curium Pharmaceuticals
- 11.5.1 Curium Pharmaceuticals Corporation Information
- 11.5.2 Curium Pharmaceuticals Overview
- 11.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Curium Pharmaceuticals Recent Developments
11.6 Jubilant DraxImage
- 11.6.1 Jubilant DraxImage Corporation Information
- 11.6.2 Jubilant DraxImage Overview
- 11.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Jubilant DraxImage Recent Developments
11.7 Dongcheng
- 11.7.1 Dongcheng Corporation Information
- 11.7.2 Dongcheng Overview
- 11.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Dongcheng Recent Developments
11.8 Lantheus
- 11.8.1 Lantheus Corporation Information
- 11.8.2 Lantheus Overview
- 11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Lantheus Recent Developments
11.9 Acrotech Biopharma.
- 11.9.1 Acrotech Biopharma. Corporation Information
- 11.9.2 Acrotech Biopharma. Overview
- 11.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Acrotech Biopharma. Recent Developments
11.10 Progenics Pharmaceuticals
- 11.10.1 Progenics Pharmaceuticals Corporation Information
- 11.10.2 Progenics Pharmaceuticals Overview
- 11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Progenics Pharmaceuticals Recent Developments
11.11 International Isotopes
- 11.11.1 International Isotopes Corporation Information
- 11.11.2 International Isotopes Overview
- 11.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.11.4 International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
- 11.11.5 International Isotopes Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Therapeutic Nuclear Medicines Industry Chain Analysis
12.2 Therapeutic Nuclear Medicines Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Nuclear Medicines Production Mode & Process
12.4 Therapeutic Nuclear Medicines Sales and Marketing
- 12.4.1 Therapeutic Nuclear Medicines Sales Channels
- 12.4.2 Therapeutic Nuclear Medicines Distributors
12.5 Therapeutic Nuclear Medicines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Therapeutic Nuclear Medicines Industry Trends
13.2 Therapeutic Nuclear Medicines Market Drivers
13.3 Therapeutic Nuclear Medicines Market Challenges
13.4 Therapeutic Nuclear Medicines Market Restraints

14 Key Findings in The Global Therapeutic Nuclear Medicines Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

世界の核医学治療市場：考察と予測 (2028年まで)

Global Therapeutic Nuclear Medicines Market Insights and Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の核医学治療の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Therapeutic Nuclear Medicines Study

15 Appendix

世界の核医学治療市場：考察と予測 (2028年まで)

Global Therapeutic Nuclear Medicines Market Insights and Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界の核医学治療の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Therapeutic Nuclear Medicines Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の核医学治療の主な市場調査結果

第15章付録